COMMUNIQUÉS West-GlobeNewswire

Albireo Announces Royalty Monetization Agreement with HealthCare Royalty Partners for Elobixibat in Japan
03/01/2018
— Albireo subsidiary eligible to receive up to $60 million under agreement — — Decision on Japanese New Drug Application for elobixibat expected in first half of 2018 — BOSTON, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Albireo [...]
BeyondSpring Appoints Life Sciences Veteran Patrick Fabbio to Board of Directors as an Independent Member
03/01/2018
NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focused on the development and commercialization of innovative cancer therapies, today [...]
PositiveID’s ExcitePCR Subsidiary to Present and Exhibit at the Seed Central Tech Showcase on January 11th
03/01/2018
Seed Central Showcase facilitates research collaboration between the seed and agbiotech industry and UC Davis to bring science to market faster Kimothy Smith, DVM, EVP and Chief Science Officer of ExcitePCR, will [...]
Emerald Health Announces $15 Million Prospectus Sale; Concurrent Secondary Sale
03/01/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF [...]
Inovalon Announces Charitable Giving for 2017
03/01/2018
BOWIE, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
Zealand Pharma major shareholder announcement: Wellington Management Group LLP, U.S.
03/01/2018
Company announcement - No.1/ 2018 Zealand Pharma major shareholder announcement: Wellington Management Group LLP, U.S. Copenhagen, January 3, 2018 - Zealand Pharma announces that it has received information from [...]
Mateon Therapeutics to Present at the 2018 Biotech Showcase
03/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]
Actinium Pharmaceuticals to Present at Biotech Showcase™ 2018 and Participate in Partnering Sessions
03/01/2018
Actinium scheduled to present on Monday, January 8, 2018 at 10:00 AM PT NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or "the Company") announced today that [...]
Checkpoint Therapeutics to Present at Biotech Showcase™ 2018
03/01/2018
NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a Fortress Biotech (NASDAQ: FBIO ) company, today announced that President and Chief Executive Officer James F. [...]
Cytokinetics Announces Progress Against Vision 2020
03/01/2018
Multiple Clinical Trials Advance Under Collaborations with Astellas and Amgen Results from Four Clinical Trials of CK-2127107 Expected in 2018 Pipeline Expands with Three New Programs Advancing from Muscle Biology [...]
Beleave Signs Letter of Intent with Seven Oaks Cannabis
03/01/2018
TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has signed a letter of intent with Seven Oaks Cannabis Inc. (“ Seven Oaks [...]
Immunovaccine to Present at 2018 Biotech Showcase™ Conference
03/01/2018
HALIFAX, Nova Scotia, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will participate in the 10th Annual [...]
Myriad Genetics Announces Expanded Research Collaboration with AstraZeneca
03/01/2018
SALT LAKE CITY, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, today announced that AstraZeneca will use the Company’s myChoice ® [...]
VBL Therapeutics Announces the Appointments of Susan Kelley and David Hastings to Its Board of Directors
03/01/2018
Senior pharmaceutical executives with extensive experience in immuno-oncology, drug development, commercializing oncology medications and finance TEL AVIV, Israel, Jan. 03, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics ( [...]
ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for Varlitinib From Array BioPharma
03/01/2018
SINGAPORE, Jan. 03, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the [...]
Dr. Tomas Navratil nommé Head of Development de Nicox
03/01/2018
Communiqué de presse Dr. Tomas Navratil nommé Head of Development de Nicox ....................................... 3 janvier 2018 - diffusion à 7:30 Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, [...]
Nicox Appoints Tomas Navratil, Ph.D., as Head of Development
03/01/2018
Press Release Nicox Appoints Tomas Navratil, Ph.D., as Head of Development ................................................ January 3, 2018 - release at 7:30 am Sophia Antipolis, France Nicox SA (Euronext Paris: [...]
Basilea reports start of clinical phase 1 study in collaboration with the U.S. Adult Brain Tumor Consortium to explore BAL101553 in newly diagnosed glioblastoma
03/01/2018
Basel, Switzerland, January 03, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the initiation of a phase 1 study conducted under its clinical study agreement with the Adult Brain Tumor Consortium (ABTC) [...]
Novartis Kisqali® received FDA Breakthrough Therapy designation for initial endocrine-based treatment in premenopausal women with HR+/HER2- advanced breast cancer
03/01/2018
Designation based on Phase III MONALEESA-7 results demonstrating superior efficacy of Kisqali in combination with oral endocrine therapy compared to oral endocrine therapy in pre- or perimenopausal women who received no [...]

Pages